FLOATER PROTECT MULTI AKTIENANLEIHE - KRAFT HEINZ/PFIZER INC | Delayed Deutsche Boerse AG 14:03:32 2024-05-13 EDT | ||
| 100 EUR | +0.10% |
|
| Current month | +1.17% | ||
| 1 month | +1.09% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
PFIZER, INC.
Latest news about PFIZER, INC.
More news
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-05-13 | 100 | +0.10% | 0 |
| 24-05-10 | 99.94 | +0.12% | 0 |
| 24-05-09 | 99.82 | +0.09% | 0 |
| 24-05-08 | 99.73 | +0.49% | 0 |
| 24-05-07 | 99.24 | -0.14% | 0 |
Delayed Quote Deutsche Boerse AG
Last update May 13, 2024 at 02:03 pm
More quotesStatic data
| Product type | Reverse Convertibles |
|---|---|
| Buy / Sell | CALL |
| Underlying | PFIZER, INC. |
| Issuer | 
Vontobel
|
| WKN | VM7B7Z |
| ISIN | DE000VM7B7Z9 |
| Date issued | 2023-12-20 |
| Strike | 27.63 $ |
| Maturity | 2024-12-20 (221 Days) |
| Parity | 0.03 : 1 |
| Emission price | 100 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 100.7 € |
|---|---|
| Lowest since issue | 97.57 € |
Company Profile
Pfizer, Inc. is the world's leading pharmaceutical group. Net sales break down by family of products as follows:
- primary care products (72.8%): medicines used in internal medicine, vaccines, medicines for the prevention and treatment of Covid-19, antivirals, mRNA-based products, etc.;
- specialty care products (13.8%): medicines used in immunology, in hospitals and for the treatment of rare diseases, anti-inflammatory medicines, etc.;
- oncology products (12.1%);
- other (1.3%).
At the end of 2022, the group had more than 35 manufacturing sites worldwide.
Net sales are distributed geographically as follows: the United States (42.3%), Europe (21.9%) and other (35.8%).
Sector
-
Consensus: Pfizer, Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
25
Last Close Price
28.01
USD
Average target price
31.94
USD
Spread / Average Target
+14.02%
- Stock Market
- Certificates
- Certificat
